Fig. 1.
Figure 2.
Figure 3.
Fig. 4.
Fig. 5.
Fig. 6.
Fig. 7.
Fig. 8.
Fig. 9.
Fig. 10.
Fig. 11.
Fig. 12.
Fig. 13.
Fig. 14.
Fig. 15.
Descriptive statistics on D1
| SOFA | APACHE II (points) | SAPS II (points) | NLR | COHb | |
|---|---|---|---|---|---|
| Minimum | 1.000 | 7.000 | 17.00 | 0.7420 | 0.000 |
| 25% Percentile | 6.000 | 14.00 | 34.50 | 8.236 | 0.4250 |
| Median | 9.000 | 22.00 | 56.00 | 14.14 | 1.100 |
| 75% Percentile | 13.00 | 30.00 | 72.00 | 25.01 | 1.500 |
| Maximum | 19.00 | 44.00 | 118.0 | 59.67 | 2.500 |
| Range | 18.00 | 37.00 | 101.0 | 58.93 | 2.500 |
| Mean | 9.459 | 22.30 | 54.61 | 17.06 | 1.080 |
| Std.Deviation | 4.700 | 9.426 | 21.84 | 11.76 | 0.6356 |
| Std. Error of Mean | 0.6017 | 1.207 | 2.796 | 1.505 | 0.08206 |
Site of infection and aetiology of infection of patients included in the study_
| Site of infection | Number of patients | Aetiology | Number of patients |
|---|---|---|---|
| Pulmonary | 36 | Pneumonia / Bronchopneumonia | 33 |
| Abdominal | 27 | Peritonitis | 12 |
| Cutaneous | 5 | Intestinal obstruction | 5 |
| Urinary tract | 4 | Enterocolitis | 2 |
| Bloodstream | 3 | Sepsis / septic shock of unknown origin | 2 |
| Soft tissue | 3 | Pancreatitis | 3 |
| Biliary tract | 1 | Urinary tract infection | 2 |
| Unspecified | 1 | Cutaneous abscess | 5 |
| Prosthetic joint infection | 1 |
Descriptive statistics on D5
| SOFA | APACHE II (points) | SAPS II (points) | NLR | COHb | |
|---|---|---|---|---|---|
| Minimum | 0.000 | 5.000 | 15.00 | 0.7860 | 0.000 |
| 25% Percentile | 2.000 | 11.00 | 29.00 | 5.422 | 0.600 |
| Median | 7.000 | 18.00 | 46.00 | 9.005 | 1.000 |
| 75% Percentile | 12.00 | 27.00 | 61.00 | 17.87 | 1.500 |
| Maximum | 19.00 | 34.00 | 85.00 | 46.75 | 17.00 |
| Range | 19.00 | 29.00 | 70.00 | 45.96 | 17.00 |
| Mean | 7.359 | 18.74 | 45.36 | 13.03 | 1.471 |
| Std. Deviation | 5.334 | 9.318 | 20.40 | 10.84 | 2.550 |
| Std. Error of Mean | 0.8541 | 1.492 | 3.267 | 1.714 | 0.3982 |
Pathogens associated with infection of patients involved in the study_
| Pathogens | Number of patients | |
|---|---|---|
| Pseudomonas aeruginosa | 9 | |
| Klebsiella pneumoniae | CPE | 8 |
| BLSE | 2 | |
| unspecified | 2 | |
| Acinetobacter baumanii | 13 | |
| Proteus vulgaris | 2 | |
| Enterococcus faecalis | 5 | |
| Escherichia coli | BLSE | 4 |
| unspecified | 3 | |
| Staphylococcus arureus | MRSA | 1 |
| MSSA | 2 | |
| Streptococcus pneumoniae | 1 | |
| Candida spp. | 8 | |
| Clostridiumdifficile | 3 | |
| Other | 16 | |
| MDR | Yes | 13 |
| No | 48 | |
Predictability of mortality by NLR and COHb variation from D1 to D5 of survivors and non-survivors
| Survivors (n = 15) | Non-survivors (n = 46) | |
|---|---|---|
| NLRD1 ↓ D5 and COHb D1 ↓ D5 | 11 | 9 |
| NLRD1 ↓ D5 and COHb D1 ↑ D5 | 1 | 14 |
| NLRD1 ↑ D5 and COHb D1 ↑ D5 | 2 | 3 |
| NLRD1 ↑ D5 and COHb D1 ↓ D5 | 0 | 4 |
| NLR only on D1 and COHb only on D1 | 1 | 16 |